Skip to main content
. 2019 May 8;9:7084. doi: 10.1038/s41598-019-43572-1

Table 1.

Clinical characteristics and correlation with CTC count in 113 pre-treated HCC patients.

Clinical Characteristics (N = 113) Total CTC Epithelial CTC Biophenotypic CTC Mesenchymal CTC
≥3 <3 P ≥1 <1 P ≥1 <1 P ≥1 <1 P
All 89 24 52 61 98 15 57 56
Age, years 0.088 0.238 0.113 0.280
  >50 58 20 33 45 65 13 42 36
  ≤50 31 4 19 16 33 2 15 20
Sex 0.778 0.297 0.801 0.982
  Male 84 23 48 59 93 14 54 53
  Female 5 1 4 2 5 1 3 3
HBsAg 0.863 0.992 0.812 0.794
  Negative 10 3 6 7 11 2 7 6
  Positive 79 21 46 54 87 13 50 50
Child-Pugh score 0.138 0.085 0.994 0.754
  A 75 23 42 56 85 13 50 48
  B 14 1 10 5 13 2 7 8
Liver cirrhosis 0.754 0.383 0.698 0.780
  No 44 11 23 32 47 8 27 28
  Yes 45 13 29 29 51 7 30 28
AFP 0.757 0.209 0.510 0.064
  <20 ng/mL 34 10 17 27 37 7 27 17
  ≥20 ng/mL 55 14 35 34 61 8 30 39
No. of tumors 0.225 0.449 0.447 0.500
  Single 47 16 27 36 56 7 30 33
  Multiple 42 8 25 25 42 8 27 23
Tumor size 0.192 0.973 0.725 0.109
  <5 cm 35 13 22 26 41 7 20 28
  ≥5 cm 54 11 30 35 57 8 37 28
Vascular invasion 0.614 0.410 0.856 0.957
  No 66 19 41 44 74 11 43 42
  Yes 23 5 11 17 24 4 14 14
BCLC stage 0.189 0.440 0.918 0.290
  0 + A 28 11 16 23 34 5 17 22
  B + C 61 13 36 38 64 10 40 34